Roche and Pharmasset To Present the R7128 Monotherapy Resistance Profile
Novavax CEO to Present at BIO CEO & Investor Conference
Issuers of news releases and not PR Newswire are solely responsible for the accuracy of the content. Terms and conditions, including restrictions on redistribution, apply. Copyright © 1996-2007 PR Newswire Association LLC. All Rights Reserved. A United Business Media company.